The global amyotrophic lateral sclerosis treatment market is undergoing gradual yet impactful transformation, driven by ...

Exposure to toxic cyanobacterial blooms may accelerate fatal outcomes in amyotrophic lateral sclerosis linked to ...

When Mindy Uhrlaub got tested to see if she was a carrier of the fatal mutation that causes the amyotrophic lateral sclerosis (ALS) her mom had, her neurogeneticist at Stanford told her that if she ...

Researchers have developed a gene therapy that significantly slowed motor function loss in preclinical models of amyotrophic ...

Denali Therapeutics remains an intriguing clinical-stage biotech focused on neurodegenerative and lysosomal storage diseases.

Sandusky native Jim Obergefell and former Ohio Health Director Rick Hodges weren't so at odds as it would seem, with Hodges ...

The experimental ALS treatment usnoflast exhibited promising signs of slowed functional decline and improved breathing in a ...

Clinicians surveyed note the benefits of palliative care for people with ALS, along with barriers to its integration into ...

Cedars-Sinai has created a lifelike model of the mysterious and fatal disease that could help identify a cause of the illness ...

An iPSC-based ALS-on-a-chip model that mimics disease progression and reveals altered glutamate signaling in motor neurons ...

A year after the June 26, 2015, decision, lead plaintiff Jim Obergefell was asked at an LGBTQ+ advocacy organization's event ...

Amyotrophic lateral sclerosis (ALS) is a fast-progressing neurodegenerative disease with an average survival time of three years and no effective treatments. In ALS, motor neurons in the spinal cord, ...